You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

  • Technology appraisal guidance
  • Reference number: TA261
  • Published:  25 July 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: comments on the ACD from the public through the NICE website

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: comments on the ACD from the public through the NICE website Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: comments on the ACD from the public through the NICE website
01 June 2012
(37.47 Kb 10 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 28 May 2012

Back to top